Veterinary Blood Transfusion: Blood Types and Crossmatching

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Pretransfusion testing in veterinary medicine, encompassing blood typing and crossmatching, is critical for preventing hemolytic transfusion reactions. Blood typing identifies major red blood cell antigens (DEA 1 in dogs, AB system in cats), while crossmatching detects recipient antibodies against donor red cells (major crossmatch) and donor antibodies against recipient red cells (minor crossmatch).
• Canine blood transfusions are primarily guided by the DEA 1 antigen system, with DEA 1 negative dogs being preferred donors. However, other antigens like Dal can cause sensitization, necessitating crossmatching, especially in previously transfused or pregnant dogs, to detect alloantibodies beyond DEA 1.
• Feline transfusions are dictated by the AB blood group system, with type B cats possessing potent naturally occurring anti-A antibodies, making type A blood transfusions life-threatening. AB-matched transfusions are mandatory, and crossmatching is strongly recommended for all feline transfusions to ensure compatibility.
• Both major and minor crossmatches are recommended for all transfusions, with the major crossmatch being paramount for detecting recipient antibodies against donor red cells. In cats, the minor crossmatch is more clinically relevant due to the potential for donor plasma antibodies to affect recipient red cells, particularly with fresh whole blood.
• Crossmatching methods include traditional tube agglutination and modern gel column technology, each with advantages in cost, standardization, and ease of use. Accurate sample collection, handling, and interpretation are crucial to avoid errors such as sample misidentification or misinterpretation of weak agglutination.
• Emergency transfusions necessitate a risk-benefit assessment, where rapid gel crossmatching (approx. 15 minutes) can be performed while preparing blood. In dire situations, DEA 1 negative canine blood or type A feline blood may be administered with intensive monitoring, acknowledging the potential for incompatibility.

This article provides a practical framework for blood typing and crossmatching in dogs and cats, written for the practicing veterinarian who performs or supervises pretransfusion testing. It covers the clinically relevant blood group systems, the serologic principles underlying compatibility testing, and the procedural steps for major and minor crossmatch. The goal is to support safe transfusion decisions in first-opinion and referral settings, with attention to the limitations of each testing method.

Pretransfusion testing serves two distinct purposes. Blood typing identifies the patient's and donor's red blood cell antigens. Crossmatching detects serologic incompatibility between a specific donor and recipient, including incompatibilities that blood typing alone cannot predict. Both procedures are recommended before any red blood cell transfusion, and their importance increases in patients with prior transfusion exposure or pregnancy, because these patients may have developed alloantibodies to red cell antigens beyond the routinely typed systems Tocci and Ewing, pretransfusion testing overview.

At a Glance

Canine Blood Groups

The canine erythrocyte antigen (DEA) system comprises more than a dozen recognized blood groups, though typing reagents are commercially available for only a limited number. DEA 1 is the most clinically significant antigen. It exists as DEA 1.1 and DEA 1.2, and dogs are classified as DEA 1 positive or DEA 1 negative for practical purposes. DEA 1 negative dogs are preferred as universal donors because DEA 1 positive red cells can trigger acute hemolytic transfusion reactions in sensitized DEA 1 negative recipients Giger et al., acute hemolytic transfusion reaction case.

Dogs do not possess clinically significant naturally occurring alloantibodies. Antibodies develop only after sensitization through transfusion or pregnancy. A dog that received a DEA 1.1 positive transfusion years earlier may carry high-titer anti-DEA 1.1 IgG with potent hemolytic activity, and a subsequent DEA 1.1 positive transfusion can cause fever, pigmenturia, and a failure of the packed cell volume to rise as expected Giger et al., acute hemolytic transfusion reaction case.

Additional canine antigens include DEA 3, 4, 5, and 7, and the Dal antigen. The Dal blood type was identified in Dalmatians that developed alloantibodies after sensitization, most dogs express Dal, but some Dalmatians lack it and can be sensitized by blood from Dal-positive donors Blais et al., canine Dal blood type. These antigens are not routinely typed in practice, which is why crossmatching remains essential even when DEA 1 status appears compatible.

Feline Blood Groups

The feline AB system is the only recognized blood group system in cats and comprises three types: A, B, and AB Griot-Wenk and Giger, feline blood types. Type A predominates in domestic shorthair cats, while type B frequency varies markedly by breed and geographic region. Type AB is rare and represents a distinct phenotype, not a mixture of A and B.

Unlike dogs, cats have naturally occurring alloantibodies. Type B cats possess strong anti-A antibodies that cause life-threatening acute hemolytic reactions if type A blood is administered. Type A cats have weaker anti-B antibodies, and type AB cats have no clinically significant alloantibodies. Because of these preformed antibodies, AB-matched transfusion is mandatory in cats, and blood typing alone is insufficient to guarantee safety in all cases Griot-Wenk and Giger, feline blood types.

Principles of Crossmatching

Crossmatching tests the serologic compatibility between a specific donor and recipient. The major crossmatch combines recipient plasma with donor red cells and detects recipient antibodies directed against donor antigens. The minor crossmatch combines donor plasma with recipient red cells and detects donor antibodies against recipient antigens. In dogs, the major crossmatch is the more clinically relevant test because sensitized recipients carry the antibodies that cause hemolytic reactions. In cats, both directions matter because donor plasma may contain alloantibodies against the recipient's red cells.

Crossmatching does not eliminate all transfusion risk. It detects hemolytic incompatibility but does not prevent non-hemolytic reactions such as febrile non-hemolytic reactions or allergic responses Tocci and Ewing, pretransfusion testing overview. A compatible crossmatch therefore supports, but does not guarantee, a safe transfusion.

Testing Methods

Blood typing is available through commercial card kits, gel agglutination technology, and immunochromatographic strip methods. Tube-based typing with purchased reagents remains an option for practices with laboratory capacity Lanevschi and Wardrop, principles of transfusion medicine. Gel agglutination methods have also been adapted for crossmatching in dogs and cats, offering a point-of-care alternative to traditional tube methods Tocci and Ewing, pretransfusion testing overview.

Sample quality directly affects test accuracy. Hemolyzed, lipemic, or clotted samples can produce false results, and misidentification of samples is a preventable source of error. Proper collection, handling, and labeling are prerequisites for reliable pretransfusion testing Tocci and Ewing, pretransfusion testing overview.

Limitations and Special Considerations

Blood typing and crossmatching results must be interpreted in the context of the patient's transfusion history. A previously transfused dog may have antibodies to antigens not included in the typing panel, and only a crossmatch against the specific donor unit will reveal the incompatibility Blais et al., canine Dal blood type. Similarly, a cat with discordant typing results or a history of transfusion reaction may require additional testing beyond routine typing.

Xenotransfusion, the use of canine blood in cats, has been described in emergency situations when compatible feline blood is unavailable. This practice carries a high risk of acute intravascular hemolysis, and the transfused canine red cells are cleared rapidly from the feline circulation Euler et al., xenotransfusion studies. It should be considered only as a last resort when no feline blood is available and the patient's anemia is immediately life-threatening.

Indications and Patient Selection

Blood typing and crossmatching are indicated before every red blood cell transfusion in dogs and cats, regardless of prior transfusion history. The risk of sensitization after a single transfusion is substantial, and previously transfused dogs can develop clinically significant alloantibodies that render subsequent crossmatches incompatible. In cats, the presence of naturally occurring alloantibodies against the A and B antigens makes AB-matched transfusion mandatory, and crossmatching adds a further layer of safety beyond blood typing alone.

The decision to perform a full crossmatch versus blood typing alone depends on the clinical scenario. For an initial transfusion in a previously untransfused dog, blood typing with a DEA 1 negative donor is the minimum standard. For any patient with a history of prior transfusion, pregnancy, or unknown transfusion history, a major crossmatch should be performed against each candidate donor unit. In cats, blood typing should always be accompanied by crossmatching when time permits, because the consequences of an AB mismatch are severe and rapidly fatal.

Emergency situations modify this sequence. When the patient is exsanguinating and no typed blood is available, the clinician must weigh the risk of delayed transfusion against the risk of incompatibility. In such cases, a major crossmatch using a rapid gel method can be completed in approximately 15 minutes and should be performed while blood is being prepared. If the patient is unstable enough that even this delay is unacceptable, DEA 1 negative canine blood or type A feline blood may be administered with the understanding that crossmatch incompatibility may exist and the transfusion should be monitored intensively.

Step-by-Step Crossmatch Protocol

Sample Collection and Preparation

Collect blood from both the recipient and each donor unit in EDTA for red blood cells and in plain or serum separator tubes for plasma or serum. Sample identification errors are a leading cause of pretransfusion testing failure, so label every tube at the patient's side with at least two unique identifiers. The donor sample should be collected from the unit's attached segment tubing instead of by reopening the bag, which preserves sterility.

Centrifuge the EDTA samples to separate red blood cells from plasma. Wash the red blood cells three times in physiologic saline to remove residual plasma proteins and anticoagulant that can cause false agglutination. Prepare a 2% to 5% suspension of washed red blood cells in saline for both recipient and donor.

Major Crossmatch

The major crossmatch tests recipient plasma against donor red blood cells. This is the critical test because it detects preformed antibodies in the recipient that could hemolyze or agglutinate the transfused cells. Place two drops of recipient plasma in a labeled tube, add one drop of donor red blood cell suspension, and mix gently.

Incubate the mixture at 37 degrees Celsius for 15 to 30 minutes. After incubation, centrifuge briefly and examine the supernatant for hemolysis, which indicates complement activation and is a more dangerous finding than agglutination alone. Gently resuspend the cell button and grade agglutination macroscopically. Any visible agglutination or hemolysis constitutes a positive major crossmatch and the donor unit should not be used.

Minor Crossmatch

The minor crossmatch tests donor plasma against recipient red blood cells. This test detects antibodies in the donor unit that could attack the recipient's own red cells. In practice, the minor crossmatch is less clinically important than the major crossmatch because donor plasma antibodies are diluted in the recipient's circulation and most blood components are administered as packed red blood cells with minimal residual plasma. However, when fresh whole blood is used, the minor crossmatch gains relevance because the full donor plasma volume is transfused.

Perform the minor crossmatch using the same technique as the major crossmatch, substituting donor plasma and recipient red blood cells. A positive minor crossmatch is a relative contraindication to using that unit, particularly in cats where donor alloantibody titers can be high.

Gel Column Method

Gel column technology provides a standardized alternative to tube testing. The gel matrix contains anti-human globulin or species-specific reagents, and red blood cells that have bound antibody fail to migrate through the gel during centrifugation, producing a positive reaction at the top of the column. This method reduces technician variability and provides stable, readable end points. The major limitation is cost and the requirement for species-specific gel cards, which are available for dogs and cats.

Interpretation and Documentation

Record the results for each donor unit tested, including the blood type of both recipient and donor, the major and minor crossmatch results, and the method used. A negative major crossmatch indicates that no clinically significant antibodies are detectable in the recipient against that donor's red cells. A positive result at any grade, including weak agglutination, should prompt selection of an alternative donor. Document the crossmatch result in the medical record along with the unit identification number so that the testing can be linked to the specific blood product administered.

Blood Type Selection by Species

The table below summarizes the clinically relevant blood types and the selection logic for each species.

In dogs, the DEA 1 blood group system is the most clinically significant because DEA 1.1 positive red cells can induce strong alloantibody production in DEA 1.1 negative recipients, leading to acute hemolytic transfusion reactions on subsequent exposure. The Dal blood type, first described in Dalmatians, is an additional antigen that can cause sensitization and crossmatch incompatibility despite apparent DEA compatibility. This illustrates why crossmatching, instead of blood typing alone, is the definitive compatibility test.

In cats, the AB system is the only recognized blood group system, but the distribution of types varies geographically and by breed. Type B cats have high titers of naturally occurring anti-A antibodies, so transfusion of type A blood produces immediate intravascular hemolysis. Type AB cats are rare and may have either anti-A or anti-B antibodies, making crossmatching particularly important for this group.

Equipment and Consumable Considerations

Tube crossmatching requires a centrifuge capable of achieving 1000 to 3500 rpm, a 37 degree Celsius water bath or heat block, glass or plastic test tubes, physiologic saline, and a reliable light source for agglutination grading. Gel column testing requires the proprietary gel cards, a specialized centrifuge, and a pipetting system. Both methods require EDTA and serum separator tubes for sample collection.

The choice between tube and gel methods depends on caseload, technician experience, and budget. Tube testing is inexpensive and flexible but requires careful technique and consistent interpretation. Gel testing is more expensive per test but reduces operator-dependent variability and is easier to standardize across multiple technicians. Practices that transfuse infrequently may prefer tube testing, while referral hospitals with high transfusion volumes may justify the cost of gel technology.

Species-Specific Modifications

Feline crossmatching requires attention to the strong naturally occurring alloantibodies that can cause false-positive results if testing is performed at room temperature. Incubation at 37 degrees Celsius reduces cold agglutinin interference while still detecting clinically significant warm-reactive antibodies. Feline red blood cells are also smaller than canine cells, so the centrifugation time and speed may need adjustment to achieve the correct cell button without excessive packing.

Xenotransfusion, the administration of canine blood to cats, has been described in emergency situations when feline blood is unavailable. This practice carries a high risk of acute intravascular hemolysis, and the crossmatch results are unpredictable, with both positive and negative major crossmatch reactions reported. Xenotransfusion should be reserved for situations where the patient will die without immediate oxygen-carrying support, and the clinician must inform the owner of the substantial risk of a severe transfusion reaction.

Recognized Complications and Early Detection

The most serious failure mode in veterinary transfusion is acute hemolytic transfusion reaction. In cats, naturally occurring anti-A alloantibodies in type B cats can produce life-threatening hemolysis when type A blood is administered, and this risk is present on first transfusion feline transfusion medicine and blood type importance. In dogs, clinically significant hemolysis typically requires prior sensitization. A dog transfused with DEA 1.1 positive blood can develop anti-DEA 1.1 IgG alloantibodies that persist for years, a subsequent DEA 1.1 positive transfusion can then trigger fever, pigmenturia, lethargy, and failure of the packed cell volume to rise as expected acute hemolytic transfusion reaction from DEA 1.1 incompatibility. Early detection relies on monitoring temperature, mentation, urine color, and serial PCV during the first 30 to 60 minutes of administration, with immediate cessation if any deterioration occurs.

Delayed serologic incompatibility is a second failure mode. A previously transfused or pregnant animal may have alloantibodies below the detection threshold of routine typing, yet capable of causing accelerated clearance of transfused red cells. Crossmatching before every transfusion, including in patients with a history of any prior transfusion, reduces this risk principles of transfusion medicine in small animals. The Dal blood type illustrates the limits of standard panels. Dalmatians lacking this common antigen can develop alloantibodies after sensitization, and major crossmatch incompatibility may appear against donors that are otherwise fully typed and matched canine Dal blood type in Dalmatians.

Xenotransfusion carries a distinct and severe risk profile. Canine blood administered to cats may produce transient clinical improvement followed by acute intravascular hemolysis and rapid PCV decline, with transfused canine red cells undetectable by four days after administration xenotransfusion of anemic cats with blood compatibility issues. This option should be reserved for extenuating circumstances where no feline blood is available and the owner accepts the high risk of hemolysis.

Common Errors and Corrective Actions

Sample misidentification is the most consequential error. Tubes must be labelled at the bedside with patient identification and collection time, and the crossmatch result must be linked to the specific donor unit, also to the donor's blood type increasing patient safety in veterinary transfusion medicine. A second common error is relying on blood typing alone without crossmatching. Typing detects major blood group antigens but does not detect alloantibodies to other red cell antigens, and it cannot identify sensitized patients whose antibodies target antigens outside the typed panel.

In cats, clinicians sometimes assume that type AB cats can receive any blood type. This is incorrect. Type AB cats have no strong alloantibodies, but the safest practice remains AB-matched or type A blood with a compatible crossmatch, because reagent and interpretation errors occur. Students frequently misinterpret weak agglutination on typing cards as a positive result. The corrective action is to repeat the test with a fresh sample and, if doubt persists, submit to a reference laboratory.

A further error is performing only the major crossmatch. The minor crossmatch, though less critical in dogs, can detect donor plasma antibodies against recipient red cells and is particularly relevant in cats, where donor alloantibody titres may be high principles of transfusion medicine in small animals.

Troubleshooting Table

Evidence Limitations and Referral Criteria

The evidence base for veterinary crossmatching is drawn largely from human transfusion medicine and from small case series. Tube and gel methods have not been systematically compared across all clinical scenarios, and point-of-care typing methods vary in sensitivity for weakly expressed antigens increasing patient safety in veterinary transfusion medicine. Expert opinion differs on whether crossmatching is mandatory for every first-time transfusion in dogs. Most authorities recommend it for any patient with prior transfusion or pregnancy, and for all feline transfusions, given the higher risk profile principles of transfusion medicine in small animals.

Referral to a veterinary clinical pathologist or transfusion medicine specialist is warranted when crossmatch incompatibility persists across multiple donors, when a patient has a history of transfusion reactions, or when blood typing results are discordant between methods. Regional blood banks and commercial laboratories can provide extended typing panels, including Dal and other rare antigens. Regulatory reporting obligations vary by jurisdiction, clinicians should consult their local veterinary board or professional body for requirements related to transfusion-related adverse events AVMA practice resources.

Frequently Asked Questions

How should I proceed when a crossmatch is incompatible but the transfusion is urgent?

When time or patient stability precludes finding a compatible donor, reassess whether transfusion is truly unavoidable. If it is, select the lowest-risk product available and transfuse slowly with intensive monitoring. In cats, an AB-matched unit remains the priority because naturally occurring alloantibodies can cause life-threatening hemolysis. In dogs, a first transfusion carries lower risk, but previously sensitized dogs may develop acute hemolytic reactions even years later. Document the decision, the incompatible result, and the monitoring plan in the medical record. Consider consulting a veterinary emergency or transfusion specialist before proceeding if one is reachable. Pretransfusion testing principles support crossmatching as a risk-reduction step, not an absolute guarantee of safety.

Can I use a point-of-care blood typing card alone instead of a crossmatch?

No. Blood typing and crossmatching answer different questions. Typing identifies the major blood group antigen, while crossmatching detects antibodies in the recipient's plasma against donor red cells, including antibodies to minor antigens not covered by routine typing. A type-matched but crossmatch-incompatible unit can still cause hemolysis. This is especially relevant in cats, where type A and type AB cats may have weak alloantibodies, and in previously transfused dogs. Small animal transfusion principles describe both assays as complementary screening tools. Use typing to narrow donor selection, then crossmatch the specific donor unit before transfusion whenever feasible.

What is the minimum equipment needed to perform a reliable in-house crossmatch?

A standard tube method requires only EDTA and plain or serum-separator tubes, saline, a centrifuge, pipettes, and glass or plastic test tubes. A commercial gel column system is more convenient but adds cost and requires specific reagents and an incubator. Both approaches are acceptable if the operator follows the manufacturer's instructions and interprets results carefully. Pretransfusion testing overview notes that tube methods are technically demanding, so practices must ensure staff are trained and proficiency is verified. If a centrifuge is unavailable, a gel or card method may be the only practical option, but the practice should recognize the reduced sensitivity for weak reactions and document that limitation.

How do I handle blood typing and crossmatching in a cat with a history of xenotransfusion?

Xenotransfusion with canine blood is a salvage option when compatible feline blood is unavailable, but it carries substantial risk. In reported cases, anemic cats transfused with canine blood showed transient improvement followed by acute intravascular hemolysis and rapid packed cell volume decline. Canine red cells were no longer detectable four days after transfusion. Xenotransfusion case studies demonstrate that feline plasma may show variable major crossmatch reactions with canine red cells, so a compatible result does not predict clinical safety. After xenotransfusion, subsequent feline transfusions require fresh typing and crossmatching because the patient may have developed new antibodies. Avoid xenotransfusion whenever any feline donor can be located.

What records should I keep after performing a blood type and crossmatch?

Record the patient's blood type, the donor's blood type, the crossmatch method used, the results of major and minor crossmatches, the lot numbers of any commercial reagents or cards, and the identity of the person who performed and interpreted the test. Include the date and time, the patient's packed cell volume and total protein at the time of testing, and any discrepancies between typing and crossmatch results. Professional practice resources emphasize accurate medical records as a foundation for patient safety and continuity of care. If a transfusion is given despite an incompatible crossmatch, document the clinical rationale and the monitoring protocol. These records also support investigation if a transfusion reaction occurs later.

How should I explain the need for crossmatching to a client who asks why their pet cannot simply receive blood from another dog?

Explain that blood types in dogs and cats are not interchangeable like a universal donor system. A crossmatch is a compatibility test that mixes the patient's plasma with the donor's red cells to check for antibodies that could destroy the transfused cells. In cats, giving the wrong blood type can cause a severe, life-threatening reaction. In dogs, prior transfusions can sensitize the immune system, making later transfusions dangerous even if the major blood type matches. Feline blood type clinical importance and canine transfusion reaction reports both support this explanation. Frame the test as a safety measure, not a delay, and note that it takes only minutes once a donor is available.

Related Clinical & Scientific Guides

• Toxicology in Emergency Practice: Common Poisons and Diagnostic Approach
• Veterinary Cardiopulmonary Resuscitation: Post-Cardiac Arrest Care
• Fluid Therapy Guidelines for Dogs and Cats: A Practical Update

References and Further Reading

• Increasing patient safety in veterinary transfusion medicine: an overview of pretransfusion testing.. 2009.
• Principles of transfusion medicine in small animals.. 2001.
• Canine Dal blood type: A red cell antigen lacking in some Dalmatians.. 2007.
• Xenotransfusion of anemic cats with blood compatibility issues: pre- and posttransfusion laboratory diagnostic and crossmatching studies.. 2016.
• An acute hemolytic transfusion reaction caused by dog erythrocyte antigen 1.1 incompatibility in a previously sensitized dog.. 1995.
• Feline transfusion medicine. Blood types and their clinical importance.. 1995.
• RECOVER Initiative Veterinary CPR Guidelines. Veterinary Emergency and Critical Care Society.
• AAHA/AAFP Fluid Therapy Guidelines for Dogs and Cats. AAHA.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Blood Transfusion in Dogs and Cats: Crossmatching and Compatibility
• Veterinary Blood Transfusion: Administration and Monitoring
• Veterinary Whole Blood Transfusion: Collection and Storage
• Veterinary Blood Transfusion Reactions: Recognition and Management
• Complication Recognition in Canine Blood Transfusion Reactions

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.